AstraZeneca selects miRNA oncology target under alliance with Regulus Therapeutics Oct. 30, 2013 No Comments
Merck Serono and Selvita enter oncology collaboration targeting metabolic pathways Oct. 28, 2013 No Comments
FDA awards 15 grants to support drug and device development for rare diseases Oct. 25, 2013 No Comments
Berg and Icahn School of Medicine form pharmaceutical and diagnostic R&D partnership Oct. 16, 2013 No Comments
Rational computational design of high-affinity, small-molecule-selective binding proteins Oct. 15, 2013 No Comments
RSS